The Statement-of-Work (SOW) consulting model is how they got there. This guide explains what that model is, how it works in practice, and what making the move actually involves.
The Other Side of the Ceiling
The i-Pharm GxP Guide to SOW Consulting
Free Download
What SOW Consulting in U.S. Life Sciences Manufacturing Looks Like
Some of the most significant programmes currently underway in U.S. Life Sciences manufacturing, from new state-of-the-art facilities being built from the ground up to MES implementations running across dozens of production lines and CQV programmes on aseptic and sterile sites supplying medicines to tens of millions of patients, are being delivered by a small group of senior professionals working outside of permanent employment.
U.S. Life Sciences Manufacturing
Where is the market at?
U.S. Life Sciences manufacturing is in the middle of its biggest expansion in a generation. The investment is committed, the programmes are live, and the demand for experienced professionals to deliver them has never been higher.
370000000000$
Total U.S. pharmaceutical manufacturing capacity commitments over the next 5 years, spanning greenfield builds, brownfield expansions, and operating facility upgrades.
Say hello to your GxP team
Join the i-Pharm GxP Network
Join the i-Pharm GxP network and gain access to the work that defines careers.
We deploy highly skilled GxP specialists as Owner's Representatives and SMEs on some of the most complex, business-critical projects across Life Sciences manufacturing. These are high-impact, outcome-driven engagements with the world's leading life sciences organisations, rarely visible on the open market.
Upload your CV below, and a member of our team will be in touch to understand your background, your goals, and where you can make the greatest impact - now or in the future.
